What is the recommended dose of metoclopramide (Reglan) for a pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Metoclopramide Dosing

The recommended dose of metoclopramide in pediatric patients is 0.1 mg/kg per dose (maximum 10 mg) administered orally, intramuscularly, or intravenously every 6-8 hours, with use strictly limited to 5 days or less due to the high risk of extrapyramidal reactions and tardive dyskinesia. 1, 2

Standard Dosing by Indication

Nausea/Vomiting and Gastroesophageal Reflux

  • 0.1 mg/kg per dose (maximum 10 mg) given PO/IM/IV every 6-8 hours 1, 2, 3
  • Duration must not exceed 5 days 1, 2, 3
  • Note: The American Academy of Pediatrics states there is insufficient evidence to support routine use of metoclopramide for GERD in infants or children 2, 3

Chemotherapy-Induced Nausea and Vomiting (High-Dose Regimen)

  • 1-2 mg/kg per dose IV for highly emetogenic chemotherapy (cisplatin, dacarbazine) 1, 4
  • 1 mg/kg per dose IV for less emetogenic regimens 4
  • Administer slowly over 15 minutes, given 30 minutes before chemotherapy 1, 4
  • Repeat every 2 hours for two doses, then every 3 hours for three doses 4
  • Always co-administer diphenhydramine to reduce extrapyramidal reactions 5, 6

Radiological Procedures and Small Bowel Intubation

  • Age <6 years: 0.1 mg/kg IV over 1-2 minutes 4
  • Age 6-14 years: 2.5-5 mg IV over 1-2 minutes 4
  • Age >14 years: 10 mg IV over 1-2 minutes 4

Critical Safety Warnings

Age-Based Contraindications

  • Contraindicated in children <1 year of age 1
  • Use with extreme caution in children <5 years of age 1, 7
  • The risk of extrapyramidal symptoms is significantly higher in younger children 7, 5

Extrapyramidal Reactions (Primary Concern)

  • Extrapyramidal symptoms occur in 9% (95% CI 5-17%) of pediatric patients 7
  • Risk factors include: higher doses (≥2 mg/kg), consecutive day dosing, and younger age 1, 5, 6
  • Acute dystonic reactions occurred in 15% of children receiving ≥2 mg/kg doses 6
  • If acute dystonic reaction occurs: Immediately administer diphenhydramine 1-2 mg/kg (or 25-50 mg) parenterally 1, 2, 3, 4

Duration Limitation

  • Maximum duration: 5 days due to risk of tardive dyskinesia 1, 2, 3
  • This black box warning applies to all pediatric patients 3

Additional Contraindications

  • Pheochromocytoma, seizure disorders, gastrointestinal bleeding, or gastrointestinal obstruction 2
  • Do not combine with tramadol 1

Dosing Adjustments

Renal Impairment

  • For creatinine clearance <40 mL/min: initiate at approximately one-half the recommended dosage 4
  • Metoclopramide is excreted principally through the kidneys 4

Hepatic Impairment

  • Metoclopramide undergoes minimal hepatic metabolism; safe use described in advanced liver disease with normal renal function 4

Common Adverse Effects Beyond Extrapyramidal Symptoms

  • Diarrhea: 6% (95% CI 4-9%) 7
  • Sedation: 6% (95% CI 3-12%) in multiple-dose studies 7
  • Restlessness, drowsiness, and fatigue 8
  • Life-threatening effects (dysrhythmia, respiratory distress/arrest, neuroleptic malignant syndrome) are rare 7

Key Clinical Pitfalls to Avoid

  • Never exceed 5 days of therapy regardless of indication 1, 2, 3
  • Avoid consecutive day dosing when possible, as this significantly increases extrapyramidal reaction risk 5, 6
  • Do not use doses ≥2 mg/kg without prophylactic diphenhydramine in chemotherapy protocols 5, 6
  • Do not use for routine GERD management in infants and children due to lack of efficacy evidence and significant adverse effect profile 2, 3

References

Guideline

Metoclopramide Dosing and Safety in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metoclopramida en Pacientes Pediátricos

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metoclopramide Usage in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Metoclopramide as an antiemetic agent in pediatric oncology patients.

Drug intelligence & clinical pharmacy, 1986

Research

Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985

Research

Metoclopramide: a dopamine receptor antagonist.

American family physician, 1990

Related Questions

What is the recommended dose of metoclopramide (antiemetic medication) for an 8-year-old child?
Is 10mg of Metoclopramide (intravenous) a suitable dose for a 31kg child?
What is the recommended pediatric dosing of metoclopramide for children of different ages, including intravenous and oral routes?
What is the dosage and usage of metoclopramide (metoclopramide) for pediatric patients?
What is the recommended dose for intravenous (IV) metoclopramide in children?
Is statin therapy beneficial for a prediabetic patient on Xigduo (dapagliflozin and metformin) with elevated total cholesterol, hypertriglyceridemia, and low HDL (high-density lipoprotein) levels?
What is the immediate management for a patient with a stroke infarct and a Glasgow Coma Scale (GCS) score of 10, indicating moderate impaired consciousness?
What is the approach to intravenous fluid management in patients with various conditions, such as heart failure, liver disease (e.g. cirrhosis), and kidney disease, considering their underlying medical history and potential risks for fluid overload or dehydration?
What is the management approach for a patient presenting with either encephalomalacia or a cystic brain lesion, and how do the treatment strategies differ between the two conditions?
What is the recommended administration protocol for mannitol in a patient with a stroke infarct, moderate impaired consciousness (Glasgow Coma Scale (GCS) score of 10), cerebral edema, and increased intracranial pressure?
What is the recommended treatment for a patient with paronychia, considering potential underlying conditions such as diabetes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.